Sponsor Pipeline

Humacyte, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
2
Phase 3
2
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT03005418
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma		 Trial completed
2026-07-30 NCT03005418
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma		 Primary endpoint(s) modified
2026-07-30 NCT03005418
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma		 Trial sites reduced: 32 -> 29 locations
2026-07-30 NCT03005418
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma		 date change Primary completion moved earlier: 2027-09-01 -> 2023-09-19
2026-07-30 NCT03005418
Humacyte Acellular Tissue Engineered Vessel (ATEV) in Patients With Vascular Trauma		 date change Completion moved earlier: 2027-09-01 -> 2026-05-15
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-13 NCT07762313 An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit… Phase 3 Not Yet Recruiting
2026-08-13 NCT07762794 Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting… Phase 4 Not Yet Recruiting
2026-07-28 NCT07730528 Study to Evaluate the Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
2
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07762794 Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting… Vascular Injury Not Yet Recruiting
Phase 3
NCT05908084 To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage… End Stage Renal Disease (ESRD) Active, Not Recruiting
NCT07762313 An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit… Vascular Trauma Not Yet Recruiting
Phase 2
NCT07730528 Study to Evaluate the Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel… Coronary Artery Disease Not Yet Recruiting
Disease Areas
Chronic Kidney Disease (1) Coronary Artery Disease (1)
Get alerts when Humacyte, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free